Combination Chemotherapy in Treating Children With Very High Risk Acute Lymphocytic Leukemia - Related Studies

Combination Chemotherapy in Treating Children With Very High Risk Acute Lymphocytic Leukemia

This study is ongoing, but not recruiting participants.

Study NCT00003783. Last updated on August 23, 2008. Information provided by National Cancer Institute (NCI)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Leukemia

2	Additional conditions recognized in this trial
		Leukemia, Lymphoid
		Precursor Cell Lymphoblastic Leukemia-Lymphoma

3	More general conditions related to this trial
		Immune System Diseases
		Immunoproliferative Disorders
		Lymphatic Diseases
		Lymphoproliferative Disorders
		Neoplasms
		Neoplasms by Histologic Type

4	Interventions listed in this trial
		asparaginase
		cyclophosphamide
		cytarabine
		daunorubicin hydrochloride
		dexamethasone
		etoposide
		filgrastim
		idarubicin
		leucovorin calcium
		mercaptopurine
		methotrexate
		prednisone
		vincristine sulfate
		radiation therapy

5	Additional drug interventions recognized in this trial
		6-Mercaptopurine
		Daunorubicin
		Leucovorin
		Vincristine

6	More general drug interventions related to this trial
		Abortifacient Agents
		Abortifacient Agents, Nonsteroidal
		Alkylating Agents
		Anti-Infective Agents
		Anti-Inflammatory Agents
		Antibiotics, Antineoplastic
		Antiemetics
		Antimetabolites
		Antimetabolites, Antineoplastic
		Antimitotic Agents
		Antineoplastic Agents
		Antineoplastic Agents, Alkylating
		Antineoplastic Agents, Hormonal
		Antineoplastic Agents, Phytogenic
		Antirheumatic Agents
		Antiviral Agents
		Autonomic Agents
		Central Nervous System Agents
		Dermatologic Agents
		Enzyme Inhibitors
		Folic Acid Antagonists
		Gastrointestinal Agents
		Glucocorticoids
		Growth Substances
		Hormones
		Hormones, Hormone Substitutes, and Hormone Antagonists
		Immunologic Factors
		Immunosuppressive Agents
		Micronutrients
		Mitosis Modulators
		Molecular Mechanisms of Pharmacological Action
		Myeloablative Agonists
		Nucleic Acid Synthesis Inhibitors
		Peripheral Nervous System Agents
		Pharmacologic Actions
		Physiological Effects of Drugs
		Reproductive Control Agents
		Therapeutic Uses
		Tubulin Modulators
		Vitamin B Complex
		Vitamins

7	Sponsors listed in this trial
		Pediatric Oncology Group
		National Cancer Institute (NCI)